Amal Rayan

550 total citations
34 papers, 413 citations indexed

About

Amal Rayan is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Amal Rayan has authored 34 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Amal Rayan's work include Immune Cell Function and Interaction (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune cells in cancer (7 papers). Amal Rayan is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune cells in cancer (7 papers). Amal Rayan collaborates with scholars based in Egypt, United States and Saudi Arabia. Amal Rayan's co-authors include Asmaa M. Zahran, ‏Helal F. Hetta, Moien Kanaan, Karen B. Avraham, Hashem Shahin, Mary‐Claire King, Tom Walsh, Omnia El‐Badawy, Ming K. Lee and Tama Sobe and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Amal Rayan

32 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amal Rayan Egypt 13 142 135 120 108 59 34 413
G Taborelli Italy 14 57 0.4× 252 1.9× 90 0.8× 72 0.7× 104 1.8× 28 590
Shiann-Yann Lee Taiwan 10 90 0.6× 56 0.4× 31 0.3× 162 1.5× 9 0.2× 18 375
Dong-Il Sun South Korea 8 154 1.1× 64 0.5× 34 0.3× 76 0.7× 22 0.4× 11 485
JA Chiorini United States 10 99 0.7× 70 0.5× 54 0.5× 44 0.4× 7 0.1× 12 326
XL Zhang China 12 182 1.3× 21 0.2× 18 0.1× 46 0.4× 23 0.4× 31 382
Nicolas Dérian France 9 73 0.5× 350 2.6× 53 0.4× 76 0.7× 9 0.2× 15 681
G. Besbes Tunisia 11 61 0.4× 17 0.1× 83 0.7× 39 0.4× 36 0.6× 72 381
Nicole L. Hoppman United States 14 279 2.0× 31 0.2× 19 0.2× 55 0.5× 6 0.1× 62 704
Mengge Yang China 8 75 0.5× 78 0.6× 12 0.1× 20 0.2× 10 0.2× 36 301
Barry T. Shannon United States 12 105 0.7× 65 0.5× 17 0.1× 41 0.4× 33 0.6× 31 388

Countries citing papers authored by Amal Rayan

Since Specialization
Citations

This map shows the geographic impact of Amal Rayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amal Rayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amal Rayan more than expected).

Fields of papers citing papers by Amal Rayan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amal Rayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amal Rayan. The network helps show where Amal Rayan may publish in the future.

Co-authorship network of co-authors of Amal Rayan

This figure shows the co-authorship network connecting the top 25 collaborators of Amal Rayan. A scholar is included among the top collaborators of Amal Rayan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amal Rayan. Amal Rayan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Hussein, Hosni A. M., Sabry Younis Mahmoud, Eman S. Farrag, et al.. (2023). Memory T Cells Discrepancies in COVID-19 Patients. Microorganisms. 11(11). 2737–2737. 6 indexed citations
5.
6.
Zahran, Asmaa M., et al.. (2022). Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer. PLoS ONE. 17(1). e0262650–e0262650. 15 indexed citations
7.
Zahran, Asmaa M., et al.. (2021). Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Can Boost Immune Disruption. Cancer Management and Research. Volume 13. 6019–6029. 8 indexed citations
8.
Zahran, Asmaa M., et al.. (2021). Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer. PLoS ONE. 16(2). e0246806–e0246806. 28 indexed citations
9.
Zahran, Asmaa M., et al.. (2021). Microparticles and PD1 interplay added a prognostic impact in treatment outcomes of patients with multiple myeloma. Scientific Reports. 11(1). 17681–17681. 1 indexed citations
10.
Zahran, Asmaa M., Amal Rayan, Amira Osman, et al.. (2021). Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia. Scientific Reports. 11(1). 15039–15039. 19 indexed citations
11.
Hetta, ‏Helal F., Amal Rayan, Gaber El‐Saber Batiha, et al.. (2021). Prognostic Role of Monocytic Myeloid-Derived Suppressor Cells in Advanced Non-Small-Cell Lung Cancer: Relation to Different Hematologic Indices. Journal of Immunology Research. 2021. 1–10. 15 indexed citations
12.
13.
Zahran, Asmaa M., et al.. (2020). Upregulation of CD146 in Pediatric B‐Cell Acute Lymphocytic Leukemia and Its Implications on Treatment Outcomes. Journal of Immunology Research. 2020(1). 9736159–9736159. 2 indexed citations
14.
Rayan, Amal, et al.. (2020). Genetic polymorphisms in XRCC1, OGG1, and XRCC3 DNA repair genes and DNA damage in radiotherapy workers. Environmental Science and Pollution Research. 27(35). 43786–43799. 6 indexed citations
15.
16.
Rayan, Amal, et al.. (2019). The Impact of Neutrophil to Lymphocytic Ratio (NLR) as a Predictor of Treatment Outcomes in Rectal Carcinomas: A Retrospective Cohort Study. Journal of Cancer Therapy. 10(9). 755–777. 1 indexed citations
17.
Zahran, Asmaa M., et al.. (2018). Frequency and Implications of Natural Killer and Natural Killer T Cells in Hepatocellular Carcinoma.. PubMed. 25(2). 45–52. 17 indexed citations
18.
Rayan, Amal, et al.. (2018). Efficacy of Docetaxel and Oxaliplatin Regimen as a Second-Line Therapy for Patients with Advanced Pancreatic Adenocarcinoma. Journal of Gastrointestinal Cancer. 50(3). 519–524. 3 indexed citations
19.
Shahin, Hashem, Amal Rayan, Karen B. Avraham, et al.. (2010). Nonsense mutation of the stereociliar membrane protein gene PTPRQ in human hearing loss DFNB84. Journal of Medical Genetics. 47(9). 643–645. 34 indexed citations
20.
Shahin, Hashem, Tom Walsh, Tama Sobe, et al.. (2005). Mutations in a Novel Isoform of TRIOBP That Encodes a Filamentous-Actin Binding Protein Are Responsible for DFNB28 Recessive Nonsyndromic Hearing Loss. The American Journal of Human Genetics. 78(1). 144–152. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Taborelli Breakdown of academic impact, for papers by Shiann-Yann Lee Breakdown of academic impact, for papers by Dong-Il Sun Breakdown of academic impact, for papers by JA Chiorini Breakdown of academic impact, for papers by XL Zhang Breakdown of academic impact, for papers by Nicolas Dérian Breakdown of academic impact, for papers by G. Besbes Breakdown of academic impact, for papers by Nicole L. Hoppman Breakdown of academic impact, for papers by Mengge Yang Breakdown of academic impact, for papers by Barry T. Shannon
Rankless by CCL
2026